Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus

Am J Cardiol. 2002 Feb 1;89(3):318-22. doi: 10.1016/s0002-9149(01)02232-9.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Angioplasty, Balloon, Coronary
  • Chromans / administration & dosage
  • Chromans / therapeutic use*
  • Coronary Angiography
  • Coronary Artery Disease / complications*
  • Coronary Artery Disease / surgery
  • Coronary Restenosis / diagnostic imaging
  • Coronary Restenosis / pathology
  • Coronary Restenosis / prevention & control*
  • Diabetes Mellitus, Type 2 / complications*
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Middle Aged
  • Stents
  • Thiazoles / administration & dosage
  • Thiazoles / therapeutic use*
  • Thiazolidinediones*
  • Treatment Outcome
  • Troglitazone

Substances

  • Chromans
  • Hypoglycemic Agents
  • Thiazoles
  • Thiazolidinediones
  • Troglitazone